Skip to main content

. 1977 Jun;60(2):319P.

Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).

T C Orton, C Lowery, W E Lindup

PMCID: PMC1667410 PMID: 880481

319P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Amos H. E., Brigden W. D., McKerron R. A. Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. Br Med J. 1975 Mar 15;1(5958):598–600. doi: 10.1136/bmj.1.5958.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
Behan P. O., Behan W. M., Zacharias F. J., Nicholls J. T. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet. 1976 Nov 6;2(7993):984–987. doi: 10.1016/s0140-6736(76)90831-x. [DOI] [PubMed] [Google Scholar]
Potter W. Z., Davis D. C., Mitchell J. R., Jollow D. J., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther. 1973 Oct;187(1):203–210. [PubMed] [Google Scholar]
Wall-Manning H. J. Problems with practolol. Drugs. 1975;10(5-6):336–341. doi: 10.2165/00003495-197510050-00003. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (281.2 KB)

RESOURCES